GERM-LINE EXCLUSION OF A SINGLE P53 ALLELE BY PREMATURE TERMINATION OF TRANSLATION IN A LI-FRAUMENI SYNDROME FAMILY

被引:0
|
作者
STOLZENBERG, MC
BRUGIERES, L
GARDES, M
DESSARPSFREICHEY, F
CHOMPRET, A
BRESSAC, B
LENOIR, G
BONAITIPELLIE, C
LEMERLE, J
FEUNTEUN, J
机构
[1] INST GUSTAVE ROUSSY,ONCOL MOLEC LAB,CNRS,URA 1158,F-94805 VILLEJUIF,FRANCE
[2] INST GUSTAVE ROUSSY,DEPT PEDIAT ONCOL,F-94805 VILLEJUIF,FRANCE
[3] INSERM,U155,UNITE RECH EPIDEMIOL GENET,F-75016 PARIS,FRANCE
[4] INST GUSTAVE ROUSSY,UNITE DIAGNOST MOLEC,F-94805 VILLEJUIF,FRANCE
[5] INT AGCY RES CANC,F-69372 LYON 08,FRANCE
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Germline p53 mutations have been detected in approximately half of the families affected by the Li-Fraumeni syndrome (LFS), in which they are believed to represent the genetic status predisposing to multiple cancers. Failure to detect mutations in the other half of LFS families suggests that sequence analysis, which has been limited to the p53 gene coding region, have overlooked other genetic events lying outside of this region or/and that alterations in other gene(s) than p53 may also lead to the syndrome. In this report, we present the evidence that a single base pair deletion in the p53 coding sequence, leading to premature signal termination of translation, generates a null allele by preventing transport of mutant allele mRNAs into the cytoplasm. This allelic exclusion which confers a status of unizygote vis-a-vis the wild-type p53 gene to individuals who carry the mutant allele, leads to predisposition to multiple cancers in a Li-Fraumeni family. Thus, the loss of the wild-type p53 allele appears as the rate limiting step in tumor induction.
引用
收藏
页码:2799 / 2804
页数:6
相关论文
共 50 条
  • [21] Characterization of p53 oligomerization domain mutations isolated from Li-Fraumeni and Li-Fraumeni like family members
    Lomax, ME
    Barnes, DM
    Hupp, TR
    Picksley, SM
    Camplejohn, RS
    ONCOGENE, 1998, 17 (05) : 643 - 649
  • [22] The function of a heterozygous p53 mutation in a Li-Fraumeni syndrome patient
    Li, Yang
    Li, Ting
    Tang, Yuejia
    Zhan, Zhiyan
    Ding, Lixia
    Song, Lili
    Yu, Tingting
    Yang, Yi
    Ma, Jing
    Zhang, Yingwen
    Zhou, Ying
    Gu, Song
    Xu, Min
    Gao, Yijin
    Li, Yanxin
    PLOS ONE, 2020, 15 (06):
  • [23] Novel p53 germline mutation in a patient with Li-Fraumeni syndrome
    Wong, SS
    Lozano, G
    Gaff, CL
    Gardner, RJM
    Strong, LC
    Aittomäki, K
    Lindeman, GJ
    INTERNAL MEDICINE JOURNAL, 2003, 33 (12) : 621 - U8
  • [24] Li-Fraumeni Syndrome and p53 in 2015: Celebrating their Silver Anniversary
    Malkin, David
    CLINICAL AND INVESTIGATIVE MEDICINE, 2016, 39 (01): : E37 - E42
  • [25] Germ-line mutations of TP53 in Li-Fraumeni families: An extended study of 39 families
    Varley, JM
    McGown, G
    Thorncroft, M
    SantibanezKoref, MF
    Kelsey, AM
    Tricker, KJ
    Evans, DGR
    Birch, JM
    CANCER RESEARCH, 1997, 57 (15) : 3245 - 3252
  • [26] COMPLEX REPLICATION ERROR CAUSES P53 MUTATION IN A LI-FRAUMENI FAMILY
    STRAUSS, EA
    HOSLER, MR
    HERZOG, P
    SALHANY, K
    LOUIE, R
    FELIX, CA
    CANCER RESEARCH, 1995, 55 (15) : 3237 - 3241
  • [27] Germ line BAX alterations are infrequent in Li-Fraumeni syndrome
    Barlow, JW
    Mous, M
    Wiley, JC
    Varley, JM
    Lozano, G
    Strong, LC
    Malkin, D
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (08) : 1403 - 1406
  • [28] p53 compound heterozygosity in a severely affected child with Li-Fraumeni Syndrome
    Quesnel, S
    Verselis, S
    Portwine, C
    Garber, J
    White, M
    Feunteun, J
    Malkin, D
    Li, FP
    ONCOGENE, 1999, 18 (27) : 3970 - 3978
  • [29] Investigating the interaction between the microbiome and mutant p53 in Li-Fraumeni Syndrome
    Ong, Noel Wei
    Giovino, Camilla Maria
    Fischer, Nicholas William
    Psarianos, Pamela
    Malkin, David
    CANCER RESEARCH, 2022, 82 (12)
  • [30] LINKAGE STUDIES IN A LI-FRAUMENI FAMILY WITH INCREASED EXPRESSION OF P53 PROTEIN BUT NO GERMLINE MUTATION IN P53
    BIRCH, JM
    HEIGHWAY, J
    TEARE, MD
    KELSEY, AM
    HARTLEY, AL
    TRICKER, KJ
    CROWTHER, D
    LANE, DP
    SANTIBANEZKOREF, MF
    BRITISH JOURNAL OF CANCER, 1994, 70 (06) : 1176 - 1181